BlackRock Fund Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

BlackRock Fund Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$47.6M	Buy	3,778,238 +597,336	+19%	+$11.1M	0.01%	1717
2016 Q3	$89.1M	Buy	3,180,902 +492,922	+18%	+$16.5M	0.02%	1172
2016 Q2	$94.1M	Buy	2,687,980 +300,828	+13%	+$9.46M	0.02%	1026
2016 Q1	$65.4M	Buy	2,387,152 +1,324,293	+125%	+$39M	0.02%	1266
2015 Q4	$36.4M	Buy	1,062,859 +10,345	+1%	+$323K	0.01%	1693
2015 Q3	$30.2M	Sell	1,052,514 -3,166	-0.3%	-$135K	0.01%	1743
2015 Q2	$47.2M	Buy	1,055,680 +670,711	+174%	+$25.2M	0.01%	1565
2015 Q1	$13.3M	Buy	384,969 +5,493	+1%	+$149K	﹤0.01%	2291
2014 Q4	$10.4M	Buy	+379,476	New	+$9.21M	﹤0.01%	2441

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's DPLO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 19% in Q4 2016, buying an estimated $11.1M and bringing the position to 3,778,238 shares worth $47.6M. The position accounts for 0.01% of the portfolio, ranked #1717.

BlackRock Fund Advisors first reported a position in DPLO in Q4 2014 and has held it in 9 quarters since. The position peaked at $94.1M in Q2 2016. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

BlackRock Fund Advisors held 3,778,238 shares of DIPLOMAT PHARMACY, INC. worth $47.6M as of Q4 2016.
BlackRock Fund Advisors bought 597,336 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $11.1M.
DIPLOMAT PHARMACY, INC. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1717 holding.
BlackRock Fund Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and has held it in 9 quarters since.
BlackRock Fund Advisors's DIPLOMAT PHARMACY, INC. position peaked at $94.1M in Q2 2016.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.